Skip to main content
Premium Trial:

Request an Annual Quote

Fingers Crossed, But We're Not Holding Our Breath

Derek Lowe has a post at In the Pipeline about Merck's new venture in open access. Sage, which will be headed up by Stephen Friend, is meant to "bring together genomic studies from all sorts of laboratories into a common format and database," Lowe writes. He says that challenges with IP and with varying data formats will be a major hurdle for the project -- and is none too sure the venture will "[get] off the ground at all. ... The analogy with open-source software doesn’t hold up so well with most scientific research these days, since the entry barriers (facilities, equipment, and money) are significantly higher than they are in coding."

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.